Tel:
Fax:
Email:
Creative Biolabs

Human NRG2 Knockout HeLa Cell Lysate

[CAT#: NCL2008ZP403]

Human NRG2 knockout cell lysate

Species:
Human
Cell Types:
Other Cells

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry
Product Overview

Description

This is a HeLa cell transfected lysate in which Human NRG2 has been knockout by using CRISPR/Cas9 gene editing technology.

Cell Types

Other Cells

Cell Location

Epithelial

Application Notes

To use as WB control, resuspend the lyophilizate in 50 µL of LDS* Sample Buffer to have a final concentration of 2 mg/ml. For reducing conditions, we recommend a final concentration of 0.1 M DTT.

*Usage of SDS sample buffer is not recommended with these lyophilized lysates.

Mutation Description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon5.

Passage Number

<20

Knockout Validation

Sanger Sequencing

Research Areas

Neurotransmission

Pathways

Intracellular Signaling

Species

Human
Properties

Cell State

Cell lysate

STR Analysis

Amelogenin X
D5S818: 11, 12
D13S317: 12, 13.3
D7S820: 8, 12
D16S539: 9, 10
vWA: 16, 18
TH01: 7
TPOX: 8,12
CSF1PO: 9, 10

Cell Purity

>95%

Storage

Store at -80°C. Please refer to protocols.

Research Use Only

For research use only, not for diagnostic or therapeutic use.
Target Details

Target

NRG2

Official Name

NRG2

Full Name

Neuregulin 2

Alternative Names

Neuregulin 2; Neural- And Thymus-Derived Activator For ErbB Kinases; Divergent Of Neuregulin-1; Pro-NRG2; NTAK; Pro-Neuregulin-2; Membrane-Bound Isoform; DON1; HRG2;

Gene ID

9542(Human); 100042150(Mouse); 432361(Rat)

Uniprot ID

O14511(Human); P56974(Mouse); O35569(Rat)
Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
webinar
Inquiry Basket
compare

Send inquiry